[1] Yamamoto K, Imamura H, Matsuyama Y, et al.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J].J Gastroenterol, 2010, 45(12):1272-1282.
[2] 王媛媛, 朱丽影, 钟丽华, 等.原发性肝癌患者TACE前后血清GP73动态变化[J/CD].中国肝脏病杂志:电子版, 2013, 5(2):14-18.
[3] Nanashima A, Abo T, Taura N, et al.NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival:a preliminary evaluation of an improved assay for PIVKA-Ⅱ[J].Anticancer Res, 2013, 33(6):2689-2697.
[4] Kobayashi M, Ikeda K, Kawamura Y, et al.High serum des-γ-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma[J].Cancer, 2009, 115(3):571-580.
[5] Gao P, Li M, Tian QB, et al.Diagnostic performance of des-γ-carboxy prothrombin(DCP) for hepatocellular carcinoma:a bivariate meta-analysis[J].Neoplasma, 2012, 59(2):150-159.
[6] Kaibori M, Ishizaki M, Matsui K, et al.Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma[J].J Surg Oncol, 2010, 102(5):462-468.
[7] Matsubara M, Shiraha H, Kataoka J, et al.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2012, 27(10):1602-1608.
[8] 刘传苗, 徐静.肝细胞癌血清肿瘤标志物DCP、AFP-L3和AFP的表达及临床意义[J].蚌埠医学院学报, 2012, 37(9):1031-1033.
[9] Nishikawa H, Osaki Y, Kita R, et al.Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma[J].Oncol Rep, 2014, 31(1):65-72.